Literature DB >> 16794827

PDGF and microvessel wall remodeling in adult rat lung: imaging PDGF-AA and PDGF-Ralpha molecules in progenitor smooth muscle cells developing in experimental pulmonary hypertension.

Rosemary Jones1, Diane Capen, Margaretha Jacobson, Lance Munn.   

Abstract

Smooth muscle cells are mostly absent from the walls of microvessels in the adult lung but develop in large numbers as part of the pathology of human and experimental pulmonary hypertensions (PHs). We have previously shown, in an in vivo model of experimental PH, that mesenchymal (interstitial) fibroblasts and intermediate cells are the progenitors of these cells. Although smooth muscle cell development is a defining pathophysiological feature of human PH, little is known about the angiogenic signaling molecules responsible. Here, we report data for platelet-derived growth factor AA (PDGF-AA) and PDGF-Ralpha, two components of an important signaling pathway for fibroblast and myofibroblast proliferation and migration. Using antibodies linked to protein-A gold and high-resolution imaging techniques, we analyzed the expression of these molecules as smooth muscle cells developed from progenitor cell populations and in endothelial cells of the same microvessels. PDGF-AA was highly expressed by each cell type in control lung. As PH developed, the number of antigenic sites for PDGF-AA decreased with time. PDGF-Ralpha expression levels in the control lung were low, relative to the ligand, and fell in PH. These data show, for the first time, a marked phenotypic shift in expression levels of the PDGF-AA isoform and its receptor tyrosine kinase in the progenitor smooth muscle cells developing in the microvessels of the adult hypertensive lung.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16794827     DOI: 10.1007/s00441-006-0177-5

Source DB:  PubMed          Journal:  Cell Tissue Res        ISSN: 0302-766X            Impact factor:   5.249


  6 in total

1.  A protocol for phenotypic detection and characterization of vascular cells of different origins in a lung neovascularization model in rodents.

Authors:  Rosemary C Jones; Diane E Capen; Kenneth S Cohen; Lance L Munn; Rakesh K Jain; Dan G Duda
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

2.  PDGF enhances store-operated Ca2+ entry by upregulating STIM1/Orai1 via activation of Akt/mTOR in human pulmonary arterial smooth muscle cells.

Authors:  Aiko Ogawa; Amy L Firth; Kimberly A Smith; Mary V Maliakal; Jason X-J Yuan
Journal:  Am J Physiol Cell Physiol       Date:  2011-10-26       Impact factor: 4.249

Review 3.  The Platelet-Derived Growth Factor Pathway in Pulmonary Arterial Hypertension: Still an Interesting Target?

Authors:  Julien Solinc; Jonathan Ribot; Florent Soubrier; Catherine Pavoine; France Dierick; Sophie Nadaud
Journal:  Life (Basel)       Date:  2022-04-29

4.  Multi-omics analysis reveals regulators of the response to PDGF-BB treatment in pulmonary artery smooth muscle cells.

Authors:  Jidong Chen; Xiaolei Cui; Zhengjiang Qian; Yanjiao Li; Kang Kang; Junle Qu; Li Li; Deming Gou
Journal:  BMC Genomics       Date:  2016-10-06       Impact factor: 3.969

5.  MiR-339 inhibits proliferation of pulmonary artery smooth muscle cell by targeting FGF signaling.

Authors:  Jidong Chen; Xiaolei Cui; Li Li; Junle Qu; J Usha Raj; Deming Gou
Journal:  Physiol Rep       Date:  2017-09

6.  VEGFR2+PDGFRbeta+ circulating precursor cells participate in capillary restoration after hyperoxia acute lung injury (HALI).

Authors:  Rosemary Jones; Diane E Capen; Margaretha Jacobson; Kenneth S Cohen; David T Scadden; Dan G Duda
Journal:  J Cell Mol Med       Date:  2009-05-06       Impact factor: 5.310

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.